CN206508369U - One uterine cryptomere support tube - Google Patents
One uterine cryptomere support tube Download PDFInfo
- Publication number
- CN206508369U CN206508369U CN201621124405.7U CN201621124405U CN206508369U CN 206508369 U CN206508369 U CN 206508369U CN 201621124405 U CN201621124405 U CN 201621124405U CN 206508369 U CN206508369 U CN 206508369U
- Authority
- CN
- China
- Prior art keywords
- cavity
- cryptomere
- cystic structures
- uterine
- uterine cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Surgical Instruments (AREA)
Abstract
The utility model belongs to technical field of medical instruments there is provided a uterine cryptomere support tube, the main cystic structures for including body and being located at body front end；The body is that body end connects injection valve, administration valve and liquid outlet respectively provided with pipe, drainage tube and delivery tube is full of in three cavities conduit pipe, body；The cystic structures are the double-decker that degradable absorbing material is made, and inner space is communicated with being full of pipe, and the space between internal layer and outer layer is communicated with delivery tube, and drainage tube is communicated with the external world, and shape matches with uterine cavity form when the cystic structures expand.The utility model is mainly used in the postoperative preventing and treating metrosynizesis of uteroventral operation, its is simple in construction, easy to operate, can play a part of drainage hydrops, local application while cystic structures support uterine cavity prevents adhesion promotes endometrium to repair, and cystic structures can be absorbed by the body, body Automatic-falling, without manually taking out, the date in hospital is substantially shorter, mitigates the burden of doctor and patient.
Description
Technical field
The utility model is related to technical field of medical instruments, and in particular to a uterine cryptomere support tube.
Background technology
The front and rear wall contact under physiological status of normal uterine cavity is closed up, and will not also be gone out when menstrual endometrium is stripped off
Existing adhesion, this is all because the integrality and function of basal layer are normal.Clinically have many because of physics such as operation or inflammation
Chemical factor stimulates and has damaged endometrium, causes the situation of metrosynizesis, causes patient menstrual to measure reduction, amenorrhoea, infertile
Deng.
It is postoperative in order to prevent uterine cavity from gluing again because the reasons such as Endometrial Diseases or miscarriage need to be the patient of hysteroscope operation
Even, conventional method is exactly the postoperative barrier such as placement water pocket, intrauterine device in uterine cavity, and takes heavy dose of estrogen
Class medicine, promotes inner membrance to grow.Catheter is commonly used in the prior art is used as barrier, but the water pocket of catheter is spherical
, it is impossible to uterine cavity is separated well, especially the place of cornua uteri, easily adhesion again, and palace Goniosynechiae is to cause female
The infertile key factor of property；And the water pocket of catheter is spherical, is misfitted with uterine cavity shape, after saline injection, is given
Some patientss cause great pain；In addition, the top drainage portion of catheter is longer, in order to reduce the damage to uterine cavity, often
It is required for cutting a part with scissors before secondary use, uses very inconvenient.Meanwhile, heavy dose of oral hormone class medicine has one
Determine side effect.In addition, the catheter inserted need to manually take out, cause length of patient stay longer, increase the financial burden of patient.
Therefore, in clinic, it is also very desirable to match with uterine cavity form, medicine can be effectively discharged, and the doctor of patient suffering can be reduced
Treat apparatus.
Utility model content
For defect of the prior art, the utility model provides a uterine cryptomere support tube, itself and uterine cavity shape
Shape matches, and can play a part of support isolation uterine wall well.
In order to solve the above technical problems, the utility model uses following technical scheme：
One uterine cryptomere support tube, including body and the cystic structures for being located at body front end；The cystic structures bag
Internal layer and outer layer are included, the inner space of the internal layer forms the first closed cavity, the space shape between the outer layer and internal layer
Into the second cavity, shape matches with uterine cavity form when the cystic structures expand；The body is to be set in three cavities conduit pipe, body
There are injection pipe, drainage tube and delivery tube；The body front end is cecum, and the cecum exposes the cystic structures surface, described
Cecum is provided with draining hole, is offered on body and is full of mouth and the administration in the second cavity in the first cavity
Mouthful, the draining hole, injection mouth and drug delivery port are connected with drainage tube, injection pipe and delivery tube respectively；The body end is provided with
Three branches, respectively connection is full of valve, administration valve and liquid outlet.
Specifically, some medicine outlet holes connected with the second cavity are not provided with the cystic structures outer layer equally spacedly.
Specifically, the material of the cystic structures is collagen material, PGA, polylactide or PGA
With one kind in the copolymer of polylactide.
Specifically, the injection valve and administration valve are check valve.
Specifically, the tube surfaces have scale and arrow.
Specifically, the body material is medical silica-gel material.
Specifically, the medicine outlet hole aperture is identical.
As shown from the above technical solution, the uterine cavity cryptomere support tube that the utility model is provided, general structure is simple, convenient
Use.Before use, the cystic structures shrink deflating, small volume, it is convenient that uterine cavity is entered by uterine neck；In use, by the capsule
Arrow is put into uterine cavity to shape structure in accordance with the instructions, to ensure that cystic structures are matched in palace intraluminal inflation with cavity form, by described
Scale on body, which can control, is put into depth, in order to avoid patient is damaged；The cystic structures are put into after uterine cavity safely, will
Liquid or gelatinous medicine inject second cavity by the administration valve, then by physiological saline or nontoxic gas
First cavity is injected Deng by the injection valve, is full of the first cavity, because the outer layer of cystic structures is disposed with drug
Hole, during the first cavity gradually expands, the medicine in the second cavity is extruded as the propeller of syringe, makes medicine
Patient affected part is reached in shape is sprayed, medicine goes directly affected part, it is to avoid the side effect that oral drugs are brought；Cystic structures expand completely
Afterwards, structure matches with uterine cavity shape, to reach support uterine cavity, prevent the effect of adhesion.Meanwhile, intrauterine hydrops can pass through
The drainage tube outflow is external, reduces postoperative infection, promotes endometrium reparation.Because cystic structures are inhaled by biodegradable
The material of receipts is made, and cystic structures are placed in uterine cavity can voluntarily be degraded into nontoxic material after a period of time, is not required to take out,
Body Automatic-falling, patient can voluntarily take the body come off away, therefore reduce the pain of patient, while having saved postoperative hospital
Time.
Brief description of the drawings
, below will be right in order to illustrate more clearly of the utility model embodiment or technical scheme of the prior art
The accompanying drawing used required in embodiment or description of the prior art is briefly described.In all of the figs, it is similar
Element or part are general by similar reference mark.In accompanying drawing, each element or part might not be according to actual ratios
Draw.
The structural representation for the uterine cavity cryptomere support tube that Fig. 1 provides for the utility model embodiment；
Views of the Fig. 2 for the uterine cavity cryptomere support tube shown in Fig. 1 when unexpanded；
Fig. 3 is the view after the uterine cavity cryptomere support tube expansion completely shown in Fig. 1；
Reference：
1- cystic structures；11- outer layers；12- internal layers；The cavitys of 13- first；The cavitys of 14- second；
15- medicine outlet holes；2- bodys；21- draining holes；22- is full of mouth；23- drug delivery ports；24- delivery tubes；
25- is full of pipe；26- drainage tubes；27- scales；28- arrows；Valve is administered in 3-；4- is full of valve
Embodiment
The embodiment of technical solutions of the utility model is described in detail below in conjunction with accompanying drawing.Following examples are only
For clearly illustrating the technical solution of the utility model, therefore example is only used as, and this practicality can not be limited with this
New protection domain.
Refer to Fig. 1 to Fig. 3, a uterine cryptomere support tube, it is by cystic structures 1, body 2, administration valve 3, filled
Denounce what valve 4 was constituted.The cystic structures 1 are arranged to bilayer, and internal layer 12 is internally formed the first closed cavity 13, internal layer 12 with it is outer
Space between layer 11 forms on the second cavity 14, outer layer 11 and is non-equally provided with some drugs connected with the second cavity 14
Hole 15.The body 2 through cystic structures 1 but without departing from its surface, when when doctor operating without as being replaced using catheter that
Sample cuts the longer drainage portion of drainage tube, easy to operate.
The body 2 is three cavities conduit pipe, and scale 27 and arrow 28 are carved with the outer surface of body 2, so as to safety correctly
Cystic structures are put into uterine cavity；Provided with delivery tube 24, injection pipe 25 and drainage tube 26 in body 2, the front end of body 2 is blind
End, the cecum end face is the cambered surface of rounding off, is avoided that scuffing uterine cavity inwall；The cecum is provided with what is connected with uterine cavity
Draining hole 21.It is further opened with being located on body in the first cavity 13 and is full of mouth 22 and the drug delivery port in the second cavity 14
23, the draining hole 21, injection mouth 22 and drug delivery port 23 are connected with drainage tube 26, injection pipe 25 and delivery tube 24 respectively.
The injection pipe 25 and the lower end of delivery tube 24 are respectively arranged with injection valve 4 and administration valve 3, and drainage tube lower end is diameter
The liquid outlet become larger, facilitates hydrops to flow out.The injection valve 4 is check valve with administration valve 3, prevents filling liquid and medicine
Outflow.The safety of the cystic structures 1 is put into after uterine cavity, liquid or gelatinous medicine are injected described the by the way that valve 3 is administered
Two cavitys 14, then inject the first cavity 13 by being full of valve 4 by filling liquids such as physiological saline or nontoxic gas, make first
Cavity 13 is full of, because the outer layer of cystic structures 1 is disposed with medicine outlet hole 15, during the first cavity 13 gradually expands, as
The propeller of syringe equally extrudes the medicine in the second cavity 14, and it is in spray shape to reach patient affected part to make medicine；Cystic structures 1
Completely after expansion, structure matches with uterine cavity shape, completely cuts off uterine cavity wall, prevents Asherman's syndrom.The medicine is liquid or gel
Estrogen, anti-inflammatory drug of shape etc..
The material of the cystic structures 1 for degradable absorption material (such as：Collagen material, PGA, poly- third are handed over
Copolymer of ester or PGA and polylactide etc.), nontoxic material can be degraded into human body, is finally inhaled by human body
Receive, without taking out, reduce the pain of patient.The material of body 1 is medical silica-gel material, after cystic structures 1 are degraded, body
Automatic-falling, patient voluntarily can easily take out.
Finally it should be noted that：Various embodiments above is only limited to illustrate the technical solution of the utility model, rather than to it
System；Although the utility model is described in detail with reference to the foregoing embodiments, one of ordinary skill in the art should manage
Solution：It can still modify to the technical scheme described in previous embodiment, or to which part or whole technologies
Feature carries out equivalent substitution；And these modifications or replacement, do not make essence disengaging the utility model of appropriate technical solution each
The scope of embodiment technical scheme, it all should cover among claim of the present utility model and the scope of specification.
Claims (7)
1. a uterine cryptomere support tube, including body and the cystic structures for being located at body front end, it is characterised in that：The capsule
Shape structure includes internal layer and outer layer, and the inner space of the internal layer forms the first closed cavity, between the outer layer and internal layer
Space formed the second cavity, the cystic structures expand when shape match with uterine cavity form；The body is three cavities conduit pipe,
Provided with injection pipe, drainage tube and delivery tube in body；The body front end is cecum, and the cecum exposes the cystic structures table
Face, the cecum is provided with draining hole, injection in the first cavity mouthful is offered on body and in the second cavity
Drug delivery port, the draining hole, be full of mouth and drug delivery port respectively with drainage tube, be full of pipe and delivery tube is connected；The body end
End is full of valve, administration valve and liquid outlet provided with three branches, respectively connection.
2. uterine cavity cryptomere support tube according to claim 1, it is characterised in that：Between not waited on the cystic structures outer layer
Some medicine outlet holes connected with the second cavity are provided with away from ground.
3. uterine cavity cryptomere support tube according to claim 1, it is characterised in that：The material of the cystic structures is collagen
One kind in the copolymer of protein material, PGA, polylactide or PGA and polylactide.
4. uterine cavity cryptomere support tube according to claim 1, it is characterised in that：The injection valve is list with administration valve
To valve.
5. uterine cavity cryptomere support tube according to claim 1, it is characterised in that：The tube surfaces have scale and instruction
Arrow.
6. uterine cavity cryptomere support tube according to claim 1, it is characterised in that：The body material is medical silica-gel material
Material.
7. uterine cavity cryptomere support tube according to claim 2, it is characterised in that：The medicine outlet hole aperture is identical.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201621124405.7U CN206508369U (en) | 2016-10-14 | 2016-10-14 | One uterine cryptomere support tube |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201621124405.7U CN206508369U (en) | 2016-10-14 | 2016-10-14 | One uterine cryptomere support tube |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN206508369U true CN206508369U (en) | 2017-09-22 |
Family
ID=59860117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201621124405.7U Expired - Fee Related CN206508369U (en) | 2016-10-14 | 2016-10-14 | One uterine cryptomere support tube |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN206508369U (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109009646A (en) * | 2018-08-07 | 2018-12-18 | 浙江大学 | A kind of uterine cavity barrier device |
| CN110141762A (en) * | 2019-06-17 | 2019-08-20 | 乌鲁木齐市妇幼保健院 | It is a kind of to prevent after Asherman's syndrom hysteroscope operation the Medical Devices and method of adhesion again |
| CN110974521A (en) * | 2019-11-25 | 2020-04-10 | 华中科技大学同济医学院附属协和医院 | 3D printing model for preventing uterine cavity from being sticky and manufacturing method |
-
2016
- 2016-10-14 CN CN201621124405.7U patent/CN206508369U/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109009646A (en) * | 2018-08-07 | 2018-12-18 | 浙江大学 | A kind of uterine cavity barrier device |
| CN109009646B (en) * | 2018-08-07 | 2020-05-12 | 浙江大学 | Uterine cavity barrier device |
| CN110141762A (en) * | 2019-06-17 | 2019-08-20 | 乌鲁木齐市妇幼保健院 | It is a kind of to prevent after Asherman's syndrom hysteroscope operation the Medical Devices and method of adhesion again |
| CN110974521A (en) * | 2019-11-25 | 2020-04-10 | 华中科技大学同济医学院附属协和医院 | 3D printing model for preventing uterine cavity from being sticky and manufacturing method |
| CN110974521B (en) * | 2019-11-25 | 2024-01-02 | 华中科技大学同济医学院附属协和医院 | 3D printing model for preventing uterine cavity from sticking and manufacturing method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN202776442U (en) | Packing device for treating uterine bleeding | |
| JPS5967969A (en) | Cathetel stayed in cervical canal | |
| CN206508369U (en) | One uterine cryptomere support tube | |
| CN102657546B (en) | Carrier barrier system applied to prevention and treatment of metrosynizesis | |
| CN103417272B (en) | A kind of medicine distribution type uterus support | |
| US10485962B2 (en) | System and method for delivering therapeutic agents to the uterine cavity | |
| US8821456B2 (en) | Daneshvar medication pads, suppositories and methods | |
| CN206228749U (en) | A kind of double capsule dilators of figuration | |
| CN203468711U (en) | Multifunctional intrauterine adhesion control and treatment unit | |
| RU2410047C1 (en) | Method of uterine postpartum haemorrhage treatment and double balloon catheter for its implementation | |
| CN210472770U (en) | Oviduct radiography and liquid-flowing catheter | |
| CN205612515U (en) | Be used for hemostatic device in uterus | |
| CN202859206U (en) | Carrier barrier system applied to prevention and treatment of intrauterine adhesion | |
| EP3066988B1 (en) | Skin dilator | |
| CN202859897U (en) | Cervical conformal packing and injecting device | |
| CN209916099U (en) | Multifunctional anal postoperative filling tube | |
| CN205667564U (en) | A kind of anorectal sthptic sponge | |
| CN201658690U (en) | Pressure regulating and limiting type enemator | |
| CN207323830U (en) | A kind of simple self-service urethreurynter | |
| CN106552314B (en) | With analgesia delivery device after a kind of Asherman's syndrom exclusion | |
| CN203539420U (en) | Medicine-distribution type uterus stent | |
| CN107432759A (en) | Sacculus hemostasis expander | |
| CN103055408A (en) | Gynaecology three-balloon multi-cavity catheter | |
| CN203842166U (en) | Multifunctional dual-cavity airbag cervical dilator | |
| CN209220389U (en) | A kind of postoperative Multi-function mutual apotype care device of hemorrhoid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170922 Termination date: 20181014 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |